Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Icatibant for antihistamine-unresponsive idiopathic angioedema
2011-002339-24Phase 4Completed
- Sponsor
- Barts Health NHS Trust
- Start
- May 2012
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of icatibant in idiopathic angioedema, sponsored by Barts Health NHS Trust. Primary endpoint: Time to onset of symptom relief. Started May 2012; status: completed.
02
Drugs
icatibant
03
Conditions
idiopathic angioedema
Beyond the preview
Go deeper on 2011-002339-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-002339-24.